Lacosamide 10135-0802
Product NDC
10135-0802- Manufacturer
- Marlex Pharmaceuticals, Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- July 1, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA218014
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 200 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(1)
60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (10135-802-60)